Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Aclaris Therapeutics(ACRS) GlobeNewswire News Room·2024-12-04 05:30Aclaris Therapeutics(ACRS) GlobeNewswire News Room·2024-12-04 05:30
R1Aclaris Therapeutics(ACRS) GlobeNewswire News Room·2024-12-04 05:30